Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
STAR

Strides Pharma Science Share Price

 

 

Strides Pharma Science live price: ₹1204.8. It opened at ₹1,188 vs previous close ₹1,188; intraday high/low: ₹1,208/₹1,176. The 50 & 200 DMA stand at ₹1,046.17/₹934.14.

Strides Pharma Science Performance

  • Today's Low
  • ₹1,176
  • Today's High
  • ₹1,208
  • 52 Week Low
  • ₹689
  • 52 Week High
  • ₹1,231
  • Open Price₹1,188
  • Previous Close₹1,188
  • Volume85,150
  • 50 DMA₹1,046.17
  • 100 DMA₹984.70
  • 200 DMA₹934.14

Strides Pharma Science Chart

Investment Returns

  • Over 1 Month + 11.43%
  • Over 3 Month + 37.58%
  • Over 6 Month + 34.14%
  • Over 1 Year + 62.39%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 11,105
  • P/B Ratio
  • 3.7
  • Average True Range
  • 51.37
  • EPS
  • 62.84
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 44.35
  • RSI
  • 73.88
  • MFI
  • 71.63

Latest Stock News Updates

Strides Pharma Science Results Earnings Call for Q4FY26 & Full Year

Conference Call with Strides Pharma Science Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Strides Pharma Q4 profit jumps 51% at 129 cr

Revenue from operations in the quarter up at 1,323.47 crore as compared to 1,190.39 crore in the year-ago period

Mindful Strides: Himalaya Wellness Company Unites Delhi in Walk to Champion Mental Health

A 5K community walk at Major Dhyan Chand National Stadium brought together citizens to spotlight the importance of mental well-being.

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹1,204.80
+ 16.7 (1.41%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,120.92
  • 50 Day
  • ₹1,046.17
  • 100 Day
  • ₹984.70
  • 200 Day
  • ₹934.14

Resistance and Support

1175.7 Pivot Speed
  • R3 1,258.40
  • R2 1,226.70
  • R1 1,207.40
  • S1 1,156.40
  • S2 1,124.70
  • S3 1,105.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,858.68 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 26% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 12% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 54 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-18 Audited Results & Final Dividend
2026-01-30 Quarterly Results
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science Shareholding Pattern

27.91%
8.56%
4.54%
28.68%
0.01%
20.78%
9.52%

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹1,204 As on 26 May, 2026 | 09:20

The Market Cap of Strides Pharma Science is ₹11105 Cr As on 26 May, 2026 | 09:20

The P/E ratio of Strides Pharma Science is 20 As on 26 May, 2026 | 09:20

The PB ratio of Strides Pharma Science is 3.7 As on 26 May, 2026 | 09:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23